BriaCell Therapeutics Corp

BriaCell (NASDAQ: BCTX) Announces Launch of Repurchase Program

BriaCell Therapeutics Corp. (NASDAQ: BCTX) has disclosed that it has decided to launch the repurchase program of the firm. The buyback program also includes the acquisition of more than 411,962 publicly traded BCTXW warrants in total.